Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

NCT02134977 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02134977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
March 31, 2015
Enrollment
2,816 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer